Article

Microbiome changes in patients with chronic heart failure with preserved ejection fraction correlate with fibrosis markers: Description of a Russian cohort

2020-10-21

Abstract excerpt

<title>Abstract</title> <p>Background Chronic heart failure (CHF) affects approximately 26 million people worldwide. Nearly half of CHF patients develop heart failure with preserved ejection fraction (HFpEF), which is associated with myocardial hypertrophy and fibrosis. Although chronic inflammation was suggested as a critical factor contributing to fibrosis development, a new hypothesis of CHF pathogenesis sugge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e12cdfa8-a617-5fb0-ba7d-e536fda308c1
DOI: 10.21203/rs.3.rs-94727/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Microbiome changes in patients with chronic heart failure with preserved ejection fraction correlate with fibrosis markers: Description of a Russian cohortDOI 10.21203/rs.3.rs-94727/v1Read

Alterations of the Gut Microbiota in Patients With Severe Chronic Heart FailureSemantic proximity Read

Changes in Gut Microbiome Structure and Function of Rats with Isoproterenol-Induced Heart FailureSemantic proximity Read

Microbial metabolites and heart failure: Friends or enemies?Semantic proximity Read

Insights into the associations between the gut microbiome, its metabolites, and heart failureSemantic proximity Read

Low Fibre Intake is Associated with Gut Microbiota Alterations in Chronic Heart FailureSemantic proximity Read

The role of the gut microbiota in the onset and progression of heart failure: insights into epigenetic mechanisms and agingSemantic proximity Read

Effects of Gut Microbiota and Metabolites on Heart Failure and Its Risk Factors: A Two-Sample Mendelian Randomization StudySemantic proximity Read

Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failureSemantic proximity Read

Gut Microbiome in Chronic Coronary Syndrome PatientsSemantic proximity Read

Genome-wide association analysis of gut microbiome and serum metabolomics identifies heart failure therapeutic targetsSemantic proximity Read

Dengzhanshengmai capsule alleviates heart failure and concomitantly decreases phenylacetylglutamine level, interacting with the intestinal microflora in ratsSemantic proximity Read

Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic AxisSemantic proximity Read